Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients (DETECT) Trial
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Medical, surgical or trauma ICU patients ≥18 years old.
• Patients who are expected to stay in the ICU more than 2 calendar days (unlikely to be discharged out of ICU on the day of admission or on the next day).
Locations
Other Locations
Saudi Arabia
King Abdulaziz Medical City
RECRUITING
Riyadh
Contact Information
Primary
Yaseen M Arabi
yaseenarabi@yahoo.com
+966118011111
Backup
Haifa Al Humeidi
alhumediha@mngha.med.sa
+966118011111
Time Frame
Start Date: 2023-03-21
Estimated Completion Date: 2026-12
Participants
Target number of participants: 1800
Treatments
Active_comparator: Ultrasound Group
Patients will be receiving twice weekly proximal lower limb ultrasound
No_intervention: Control Group
Proximal lower limb ultrasound will be performed as per the treating team discretion
Related Therapeutic Areas
Sponsors
Leads: King Abdullah International Medical Research Center